Scientist II, Degrader Antibody Conjugate Characterization
Nurix· Brisbane, CA
onsite mid $133k – $148k / year seen live 1 day ago
Scientist II, Degrader Antibody Conjugate Characterization Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed
This link goes straight to the employer's greenhouse page. Posted 59 days ago.We last confirmed it was open 1 day ago.